Fannie Wurtz appointed Managing Director, Amundi ETF, Indexing & Smart Beta
London, 5th April 2016, Amundi continues to develop its ETF, Indexing and Smart Beta, which are major components of the Group’s strategy. In this context, Fannie Wurtz is appointed Managing Director of the ETF, Indexing and Smart Beta business line under the supervision of Valérie Baudson, member of Amundi’s Executive Committee.
Fannie Wurtz, Managing Director, Amundi ETF, Indexing & Smart Beta.
Fannie Wurtz is Managing Director of ETF & Indexing Sales at Amundi. Prior to joining Amundi in February 2012, she was responsible for ETF Institutional Sales and Amundi ETF business development with French & Swiss institutional clients at CA Cheuvreux from 2008. Fannie has extensive experience in institutional sales which she gained as Sales Associate Director at Fidelity Investments (2003-2008), where she was in charge of relationships with Institutional clients and distributors, and at Schroders Investment Management where she managed Institutional Client relationships. Fannie started her career at State Street Bank and KPMG Audit.
Fannie holds a Masters from ESC Bordeaux
Amundi, the leading European asset manager, ranking among the top 10 global players, offers its 100 million clients - retail, institutional and corporate - a complete range of savings and investment solutions in active and passive management, in traditional or real assets.
With its six international investment hubs, financial and extra-financial research capabilities and long-standing commitment to responsible investment, Amundi is a key player in the asset management landscape.
Amundi clients benefit from the expertise and advice of 5,400 employees in 35 countries. A subsidiary of the Crédit Agricole group and listed on the stock exchange, Amundi currently manages more than €1.9 trillion of assets.
Amundi, a trusted partner, working every day in the interest of its clients and society
- Source: IPE “Top 500 Asset Managers” published in June 2022, based on assets under management as at 31/12/2021
- Boston, Dublin, London, Milan, Paris and Tokyo
- Amundi data including Lyxor as at 30/06/2022